Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APC-Cdh1-mediated Skp2 destruction

被引:227
作者
Gao, Daming [1 ]
Inuzuka, Hiroyuki [1 ]
Tseng, Alan [1 ]
Chin, Rebecca Y. [1 ]
Toker, Alex [1 ]
Wei, Wenyi [1 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
基金
美国国家卫生研究院;
关键词
LIGASE SUBUNIT SKP2; UBIQUITIN LIGASE; BREAST-CANCER; TRANSCRIPTION FACTOR; INHIBITOR P27(KIP1); PROSTATE-CANCER; NUCLEAR IMPORT; KINASE-B; EXPRESSION; CELLS;
D O I
10.1038/ncb1847
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Deregulated Skp2 function promotes cell transformation, and this is consistent with observations of Skp2 overexpression in many human cancers. However, the mechanisms underlying elevated Skp2 expression are still unknown. Here we show that the serine/threonine protein kinase Akt1, but not Akt2, directly controls Skp2 stability by a mechanism that involves degradation by the APC-Cdh1 ubiquitin ligase complex. We show further that Akt1 phosphorylates Skp2 at Ser 72, which is required to disrupt the interaction between Cdh1 and Skp2. In addition, we show that Ser 72 is localized within a putative nuclear localization sequence and that phosphorylation of Ser 72 by Akt leads to cytoplasmic translocation of Skp2. This finding expands our knowledge of how specific signalling kinase cascades influence proteolysis governed by APC-Cdh1 complexes, and provides evidence that elevated Akt activity and cytoplasmic Skp2 expression may be causative for cancer progression.
引用
收藏
页码:397 / U92
页数:23
相关论文
共 48 条
[1]
BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27 Kip1 degradation and proliferation of chronic myelogenous leukemia cells [J].
Andreu, EJ ;
Lledó, E ;
Poch, E ;
Ivorra, C ;
Albero, MP ;
Martínez-Climent, JA ;
Montiel-Duarte, C ;
Rifón, J ;
Pérez-Calvo, J ;
Arbona, C ;
Prósper, F ;
Pérez-Roger, I .
CANCER RESEARCH, 2005, 65 (08) :3264-3272
[2]
RETRACTED: A cell cycle regulatory network controlling NF-κB subunit activity and function (Retracted article. See vol. 33, pg. 1978, 2014) [J].
Barre, Benjamin ;
Perkins, Neil D. .
EMBO JOURNAL, 2007, 26 (23) :4841-4855
[3]
Control of the SCFSkp2-Cks1 ubiquitin ligase by the APC/CCdh1 ubiquitin ligase [J].
Bashir, T ;
Dorrello, NV ;
Amador, V ;
Guardavaccaro, D ;
Pagano, M .
NATURE, 2004, 428 (6979) :190-193
[4]
Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor [J].
Brunet, A ;
Bonni, A ;
Zigmond, MJ ;
Lin, MZ ;
Juo, P ;
Hu, LS ;
Anderson, MJ ;
Arden, KC ;
Blenis, J ;
Greenberg, ME .
CELL, 1999, 96 (06) :857-868
[5]
The SCF ubiquitin ligase: Insights into a molecular machine [J].
Cardozo, T ;
Pagano, M .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (09) :739-751
[6]
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 [J].
Carrano, AC ;
Eytan, E ;
Hershko, A ;
Pagano, M .
NATURE CELL BIOLOGY, 1999, 1 (04) :193-199
[7]
Protein phosphatase 2A dephosphorylation of phosphoserine 112 plays the gatekeeper role for BAD-mediated apoptosis [J].
Chiang, CW ;
Kanies, C ;
Kim, KW ;
Fang, WB ;
Parkhurst, C ;
Xie, MH ;
Henry, T ;
Yang, E .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (18) :6350-6362
[8]
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery [J].
Datta, SR ;
Dudek, H ;
Tao, X ;
Masters, S ;
Fu, HA ;
Gotoh, Y ;
Greenberg, ME .
CELL, 1997, 91 (02) :231-241
[9]
Overexpression of Skp2 in carcinoma of the cervix does not correlate inversely with p27 expression [J].
Dowen, SE ;
Scott, A ;
Mukherjee, G ;
Stanley, MA .
INTERNATIONAL JOURNAL OF CANCER, 2003, 105 (03) :326-330
[10]
Drobnjak M, 2003, CLIN CANCER RES, V9, P2613